Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W R Markesbery

Showing results (211-220 of 253) with videos related to

Pageof 26
Sort By:
Neurology|April 13, 2005
Evidence of increased oxidative damage in subjects with mild cognitive impairmentJ N Keller, F A Schmitt, S W Scheff, et al.
Alzheimer Disease and Associated Disorders|January 1, 1992
Alzheimer disease brain extract stimulates branching of laminin-mediated neuronal processesS D Kittur, H Endo, W H Adler, et al.
Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration|December 1, 1995
Neutron activation analysis of trace elements in motor neuron disease spinal cordW R Markesbery, W D Ehmann, J M Candy, et al.
Neurobiology of Aging|November 26, 2008
Prodromal clinical manifestations of neuropathologically confirmed Lewy body diseaseG A Jicha, F A Schmitt, E Abner, et al.
Journal of Neuropathology and Experimental Neurology|May 22, 1998
Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotypeK S Montine, E Reich, M D Neely, et al.
Journal of Neuropathology and Experimental Neurology|May 26, 1998
N-terminal heterogeneity of parenchymal and cerebrovascular Abeta depositsT L Tekirian, T C Saido, W R Markesbery, et al.
Neurology|October 26, 1999
Elevated CSF prostaglandin E2 levels in patients with probable ADT J Montine, K R Sidell, B C Crews, et al.
Annals of Neurology|November 18, 1998
Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patientsW A Pedersen, W Fu, J N Keller, et al.
Journal of Neurochemistry|July 20, 2001
The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42C M Lauderback, J M Hackett, F F Huang, et al.
Biochemistry|May 1, 2001
Vulnerability of synaptosomes from apoE knock-out mice to structural and oxidative modifications induced by A beta(1-40): implications for Alzheimer's diseaseC M Lauderback, J M Hackett, J N Keller, et al.
Pageof 26

Showing results (211-220 of 253) with videos related to

Sort By:
Pageof 26
Neurology|April 13, 2005
Evidence of increased oxidative damage in subjects with mild cognitive impairmentJ N Keller, F A Schmitt, S W Scheff, et al.
Alzheimer Disease and Associated Disorders|January 1, 1992
Alzheimer disease brain extract stimulates branching of laminin-mediated neuronal processesS D Kittur, H Endo, W H Adler, et al.
Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration|December 1, 1995
Neutron activation analysis of trace elements in motor neuron disease spinal cordW R Markesbery, W D Ehmann, J M Candy, et al.
Neurobiology of Aging|November 26, 2008
Prodromal clinical manifestations of neuropathologically confirmed Lewy body diseaseG A Jicha, F A Schmitt, E Abner, et al.
Journal of Neuropathology and Experimental Neurology|May 22, 1998
Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotypeK S Montine, E Reich, M D Neely, et al.
Journal of Neuropathology and Experimental Neurology|May 26, 1998
N-terminal heterogeneity of parenchymal and cerebrovascular Abeta depositsT L Tekirian, T C Saido, W R Markesbery, et al.
Neurology|October 26, 1999
Elevated CSF prostaglandin E2 levels in patients with probable ADT J Montine, K R Sidell, B C Crews, et al.
Annals of Neurology|November 18, 1998
Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patientsW A Pedersen, W Fu, J N Keller, et al.
Journal of Neurochemistry|July 20, 2001
The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42C M Lauderback, J M Hackett, F F Huang, et al.
Biochemistry|May 1, 2001
Vulnerability of synaptosomes from apoE knock-out mice to structural and oxidative modifications induced by A beta(1-40): implications for Alzheimer's diseaseC M Lauderback, J M Hackett, J N Keller, et al.
Pageof 26